{"id":"W2153865661","doi":"10.1200/jco.2007.14.4824","title":"Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":573,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Sanofi; AstraZeneca","keywords":"Medicine; Gefitinib; Docetaxel; Internal medicine; Performance status; Lung cancer; Interim analysis; Placebo; Chemoradiotherapy; Surgery; Oncology; Chemotherapy; Cancer; Clinical trial; Epidermal growth factor receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002014423,0.002192032,0.003311165,0.0005711346,0.0006019116,0.001291877,0.0016451,0.002215042,0.005994269],"category_scores_gemma":[0.001068725,0.0006299312,0.001590925,0.0006071597,0.001698769,0.001053987,0.000397179,0.003812903,0.001629077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001431938,"about_ca_system_score_gemma":0.002649358,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001664859,"about_ca_topic_score_gemma":0.004522889,"domain_scores_codex":[0.9995395,0.0002109571,0.00002353761,0.00008764854,0.00003939666,0.00009888293],"domain_scores_gemma":[0.9991688,0.0001199885,0.0001740844,0.00006874157,0.00003969709,0.0004287456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9435588,0.02019645,0.001258713,0.0003952049,0.0005944128,0.00008480733,0.0001034594,0.0007327308,0.006762007,0.0001508926,0.002377574,0.02378495],"study_design_scores_gemma":[0.8725328,0.1231807,0.002081438,0.00002120499,0.0001559404,0.00006095624,0.00002073534,0.000505967,0.0007503579,0.00006672023,0.00061096,0.00001226912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903852,0.002287841,0.0004220948,0.0006931153,0.0004261066,0.002904967,0.001063206,0.000244228,0.001573217],"genre_scores_gemma":[0.9853914,0.001446911,0.001272609,0.00106615,0.0002783258,0.004493506,0.00221564,0.00004366488,0.003792003],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005994269,"threshold_uncertainty_score":0.02005279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08398044194763006,"score_gpt":0.4845825549230046,"score_spread":0.4006021129753746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}